Lifecore Biomedical Financial Overview
Lifecore Biomedical's market cap is currently $301.23M. The company's EPS TTM is $-0.29; its P/E ratio is -6.27; Lifecore Biomedical is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $-0.14. See an overview of income statement, balance sheet, and cash flow financials.
